Illumina
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Diagnostics & Research
業務概覽 Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
公司地址 5200 Illumina Way, San Diego, CA, USA, 92122
電話號碼 +1 858 202-4500
傳真號碼 +1 858 202-4545
公司網頁 https://www.illumina.com
員工數量 10080
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Patricia Leckman Chief People Officer -- 09/04/2026
Mr. Scott M. Davies Chief Legal Officer -- 09/04/2026
Mr. Ankur Dhingra Chief Financial Officer 美元 650.00K 09/04/2026
Mr. Scott Ericksen Vice President and Chief Accounting Officer -- 12/02/2026
Dr. Steve Barnard, PhD Chief Technology Officer 美元 600.00K 09/04/2026
Mr. Christensen Jakob Wedel Chief Strategy and Corporate Development Officer -- 09/04/2026
Mr. Jacob Thaysen Director and Chief Executive Officer 美元 1.00M 09/04/2026
Mr. Kevin Carl Pegels Chief, Global Operations 美元 575.00K 09/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Caroline D. Dorsa Independent Director 09/04/2026
Ms. Anna S. Richo Independent Director 09/04/2026
Mr. David P King Independent Director 09/04/2026
Dr. Gary S. Guthart,PhD Independent Director 02/04/2026
Mr. Philip W. Schiller Independent Director 09/04/2026
Ms. Susan E. Siegel Independent Director 09/04/2026
Dr. Robert S. Epstein, M.D.,M.S. Independent Director 02/04/2026
Dr. Scott Gottlieb,M.D. Chairman of the board 09/04/2026
Dr. Frances H. Arnold, PhD Independent Director 02/04/2026
Mr. Scott B. Ullem Independent Director 09/04/2026
Mr. Keith A. Meister Independent Director 09/04/2026
Mr. Jacob Thaysen Director and Chief Executive Officer 09/04/2026
 
所屬ETF (更新日期: 02/05/2026 03:26)
代號 名稱 佔比% ▼ 持有日期
INROiShares U.S. Industry Rotation Act ETF<0.000001%10/03/2026
IVEiShares S&P 500 Value ETF<0.000001%06/03/2026
IVViShares Core S&P 500 ETF<0.000001%04/03/2026
IWFiShares Russell 1000 Growth ETF<0.000001%05/03/2026
IWPiShares Russell Mid-Cap Growth ETF<0.000001%06/03/2026
IXJiShares Global Healthcare ETF<0.000001%06/03/2026
LRNDNYLI U.S. Large Cap R&D Leaders ETF<0.000001%28/08/2025
LSAFLeaderSharesTM AlphaFactor® US Cr Eq ETF<0.000001%01/04/2026
MFMOMotley Fool Momentum Factor ETF<0.000001%02/04/2026
OPTZOptimize Strategy Index ETF<0.000001%25/03/2026
PABUiShares Paris-Algnd Clmt Optd MSCIUSAETF<0.000001%04/03/2026
PAMCPacer Lunt MidCap Multi-Factor Alt ETF<0.000001%06/04/2026
PTNQPacer Trendpilot™ 100 ETF<0.000001%04/03/2026
QDPLPacer Metaurus US Lg Cp Dvd Mltp 400 ETF<0.000001%04/03/2026
QQQHNEOS Nasdaq-100 Hdg Eq Inc ETF<0.000001%04/03/2026
QVALAlpha Architect US Quantitative Val ETF<0.000001%30/10/2025
RALSProShares RAFI® Long/Short<0.000001%30/04/2022
RCGERockCreek Global Equality ETF<0.000001%26/09/2025
SCHGSchwab US Large-Cap Growth ETF™<0.000001%23/09/2025
SHEStt Strt® SPDR® MSCI USA Gndr Divst ETF<0.000001%27/08/2025
  1    2    3    4    5    6    7    8    9    10    11    12    13   14    15  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.